BioXcel Therapeutics Inc (BTAI)
2.085
-0.22
(-9.54%)
USD |
NASDAQ |
May 10, 16:00
2.13
+0.04
(+2.16%)
After-Hours: 19:35
BioXcel Therapeutics Market Cap: 77.22M for May 10, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 09, 2024 | 85.36M |
| May 08, 2024 | 78.51M |
| May 07, 2024 | 87.03M |
| May 06, 2024 | 92.96M |
| May 03, 2024 | 95.18M |
| May 02, 2024 | 94.81M |
| May 01, 2024 | 94.07M |
| April 30, 2024 | 93.33M |
| April 29, 2024 | 95.55M |
| April 26, 2024 | 97.40M |
| April 25, 2024 | 96.66M |
| April 24, 2024 | 100.36M |
| April 23, 2024 | 109.99M |
| April 22, 2024 | 105.55M |
| April 19, 2024 | 101.84M |
| April 18, 2024 | 94.44M |
| April 17, 2024 | 95.92M |
| April 16, 2024 | 99.25M |
| April 15, 2024 | 101.84M |
| April 12, 2024 | 107.40M |
| April 11, 2024 | 103.33M |
| April 10, 2024 | 97.40M |
| April 09, 2024 | 86.43M |
| April 08, 2024 | 88.45M |
| April 05, 2024 | 89.46M |
| Date | Value |
|---|---|
| April 04, 2024 | 90.47M |
| April 03, 2024 | 88.79M |
| April 02, 2024 | 88.79M |
| April 01, 2024 | 94.84M |
| March 28, 2024 | 94.84M |
| March 27, 2024 | 96.86M |
| March 26, 2024 | 87.45M |
| March 25, 2024 | 87.14M |
| March 22, 2024 | 85.92M |
| March 21, 2024 | 86.53M |
| March 20, 2024 | 85.00M |
| March 19, 2024 | 83.17M |
| March 18, 2024 | 83.78M |
| March 15, 2024 | 81.42M |
| March 14, 2024 | 87.20M |
| March 13, 2024 | 87.20M |
| March 12, 2024 | 84.16M |
| March 11, 2024 | 88.11M |
| March 08, 2024 | 94.79M |
| March 07, 2024 | 92.36M |
| March 06, 2024 | 89.93M |
| March 05, 2024 | 91.75M |
| March 04, 2024 | 94.79M |
| March 01, 2024 | 97.53M |
| February 29, 2024 | 96.61M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
59.24M
Minimum
Feb 12 2024
1.577B
Maximum
Feb 11 2021
544.76M
Average
495.53M
Median
Market Cap Benchmarks
| Synlogic Inc | 20.85M |
| Cormedix Inc | 283.98M |
| Bristol-Myers Squibb Co | 91.08B |
| Verastem Inc | 299.14M |
| Ocular Therapeutix Inc | 839.74M |
Market Cap Related Metrics
| PS Ratio | 44.01 |
| Price | 2.085 |
| Earnings Yield | -294.5% |